Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Hepatocellular × Itraconazole × Clear all

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 10 Breast Neoplasms 5 Recurrence 4 Lymphoma, Non-Hodgkin 4 Hematologic Neoplasms 4 Wilms Tumor 3 Solid Tumor 3 Neuroblastoma 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Non-Small-Cell Lung 3 Testicular Neoplasms 2 Sezary Syndrome 2 Prostatic Neoplasms 2 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neutropenia 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Mycoses 2 Medical Oncology 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myeloid, Chronic-Phase 2

Interventions

Sorafenib 109 Nivolumab 31 pembrolizumab 25 lenvatinib 25 Bevacizumab 24 Doxorubicin 21 Radiosurgery 18 Oxaliplatin 18 Radiofrequency Ablation 17 Hepatectomy 16 Capecitabine 14 Magnetic Resonance Spectroscopy 13 Fluorouracil 13 Cisplatin 12 atezolizumab 11 Leucovorin 11 Gemcitabine 10 Ipilimumab 9 Erlotinib Hydrochloride 9 tislelizumab 8 cabozantinib 8 Sirolimus 8 Irinotecan 8 Ramucirumab 7 Embolization, Therapeutic 7 gadolinium ethoxybenzyl DTPA 6 Radiotherapy 6 Pharmaceutical Preparations 6 Mitomycin 6 Liver Transplantation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

40,110 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡